Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -431.65K | -346.74%-333.21K | -3,198.36%-234.55K | -180.80%-702.93K | -28,705.89%-635.91K | 0 | 38.73%-74.59K | 113.43%7.57K | -630.69%-250.33K | -90.86%2.22K |
| Net income from continuing operations | ---717.1K | 106.44%16.56K | -53.58%-229.43K | -28.12%-594.67K | -43.28%-188.02K | --0 | -327.79%-257.27K | 36.98%-149.38K | 53.91%-464.15K | 49.80%-131.22K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---440K | ---20K |
| Depreciation and amortization | --37.06K | 6,759.41%37.18K | 23.89%37.42K | -25.24%155.01K | 144.75%124.26K | --0 | -98.97%542 | -42.45%30.2K | -21.52%207.34K | -3.52%50.77K |
| Other non cashItems | ---23.9K | ---30.16K | 12.03%-28.76K | 34.40%-121.48K | -85.91%-88.78K | --0 | --0 | 26.66%-32.7K | 16.09%-185.19K | -11.02%-47.76K |
| Change In working capital | --272.29K | -295.89%-356.8K | -108.64%-13.78K | -122.45%-141.79K | -421.32%-483.37K | --0 | 1.86%182.14K | -7.71%159.44K | -32.03%631.66K | -45.52%150.43K |
| -Change in receivables | 2,041.47%1.61M | -4,016.50%-1.6M | -97.67%1.11K | -1,634.94%-426.65K | -1,205.38%-590.1K | 166.31%74.96K | 259.19%40.9K | -32.53%47.6K | -73.46%27.8K | -170.30%-45.21K |
| -Change in inventory | --0 | 117.07%197 | -47.95%178 | -117.40%-748 | -96.54%64 | --0 | -162.41%-1.15K | -46.89%342 | -75.40%4.3K | 2,006.19%1.85K |
| -Change in prepaid assets | ---8.9K | -124.10%-3.77K | 30.43%-2.5K | -99.69%451 | -78.56%-11.61K | --0 | -90.56%15.66K | -30.54%-3.6K | 2,742.72%147.09K | -205.89%-6.5K |
| -Change in payables and accrued expense | -1,922.95%-1.52M | 857.85%1.24M | -111.96%-13.08K | -47.13%278.44K | -59.69%114.09K | -170.54%-74.96K | 522.50%129.95K | -6.11%109.36K | -39.26%526.63K | 13.80%283.02K |
| -Change in other working capital | --192.35K | 218.14%3.79K | -91.06%513 | 109.05%6.72K | 105.06%4.18K | --0 | -120.19%-3.21K | 147.23%5.74K | -36.60%-74.16K | -92.74%-82.73K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | ---431.65K | -346.74%-333.21K | -3,198.36%-234.55K | -180.80%-702.93K | -28,705.89%-635.91K | --0 | 38.73%-74.59K | 113.43%7.57K | -630.69%-250.33K | -90.86%2.22K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 2,411.60%100K | 0 | |||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- |
| Net business purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --100K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 2,411.60%100K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 477.23K | 415.49%292.64K | 2,161.28%226.47K | 542.01%733.98K | 4,824.87%688.2K | 0 | 119.27%56.77K | -136.62%-10.99K | 114.33K | 13.97K |
| Net issuance payments of debt | --477.23K | 415.49%292.64K | 2,161.28%226.47K | 542.01%733.98K | 4,824.87%688.2K | --0 | 119.27%56.77K | -136.62%-10.99K | --114.33K | --13.97K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --477.23K | 415.49%292.64K | 2,161.28%226.47K | 542.01%733.98K | 4,824.87%688.2K | --0 | 119.27%56.77K | -136.62%-10.99K | --114.33K | --13.97K |
| Net cash flow | ||||||||||
| Beginning cash position | 1,590.83%3.87K | 146.28%44.45K | 144.68%52.52K | -62.65%21.47K | -95.65%229 | -99.35%229 | -41.98%18.05K | -62.65%21.47K | -40.17%57.47K | -84.10%5.27K |
| Current changes in cash | --45.57K | -127.71%-40.58K | -136.26%-8.07K | 186.25%31.06K | 222.85%52.29K | --0 | -528.34%-17.82K | 87.04%-3.42K | 6.68%-36.01K | -33.43%16.2K |
| End cash Position | 21,490.83%49.44K | 1,590.83%3.87K | 146.28%44.45K | 144.68%52.52K | 144.68%52.52K | -95.65%229 | -99.35%229 | -41.98%18.05K | -62.65%21.47K | -62.65%21.47K |
| Free cash from | ---431.65K | -346.74%-333.21K | -3,198.36%-234.55K | -180.80%-702.93K | -28,705.89%-635.91K | --0 | 38.73%-74.59K | 113.43%7.57K | -548.77%-250.33K | -90.86%2.22K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.